(19)
(11) EP 0 912 762 A1

(12)

(43) Date of publication:
06.05.1999 Bulletin 1999/18

(21) Application number: 97929377.0

(22) Date of filing: 30.06.1997
(51) International Patent Classification (IPC): 
G01N 33/ 50( . )
C12N 15/ 09( . )
C12Q 1/ 68( . )
G01N 33/ 574( . )
C07K 16/ 30( . )
C12P 21/ 08( . )
G01N 33/ 15( . )
G01N 33/ 577( . )
(86) International application number:
PCT/GB1997/001739
(87) International publication number:
WO 1998/000561 (08.01.1998 Gazette 1998/01)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV RO SI

(30) Priority: 28.06.1996 GB 19960013629

(71) Applicant: ZENECA LIMITED
London W1Y 6LN (GB)

(72) Inventors:
  • MARKHAM, Alexander, Fred, Clinical Science Build.
    Leeds LS2 9JT (GB)
  • GUILLOU, Pierre, John, Clinical Sciences Build.
    Leeds LS2 9JT (GB)

(74) Representative: Denerley, Paul Millington, Dr., et al 
Intellectual Property Department ZENECA Pharmaceuticals Mereside Alderley Park
Macclesfield, Chesire SK10 4TG
Macclesfield, Chesire SK10 4TG (GB)

   


(54) REG GENE EXPRESSION IN CANCER TISSUE